This mixed-methods study maps psychosocial and behavioral profiles across six GLP-1 receptor agonist (GLP-1RA) weight management stages, identifying perceived competence as the single robust differentiator and suggesting stage-tailored behavioral support for pharmacists involved in obesity care.
📅 Journal publication: Sep 2026(online Aug 10, 2026)·Last updated: Oct 8, 2026
Patient competence levels influence success with GLP-1 therapy for weight loss.
Understanding patient perspectives on GLP-1 receptor agonists (GLP-1RAs) for weight management can guide personalized treatment strategies. Perceived competence was a significant differentiator; those achieving weight goals had higher perceived competence. The study highlights the need for tailored behavioral support based on patients' stage of engagement with GLP-1RA therapy. Perceived competence affects success in GLP-1RA weight management.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?
Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.